To compare the performance of unbiased high-throughput sequencing with pathogendirected PCR using DNA isolated from archived ocular fluid, approaches that are compatible with the current sample handling practice of ophthalmologists.
INTRODUCTION
The detection and validation of intraocular infections heavily rely on molecular diagnostics. Ocular samples can be challenging since as little as 100-300 µL of intraocular fluid can be safely obtained at any given time for diagnostic testing. The most widely available molecular diagnostic panel for infections in ophthalmology includes 4 separate pathogen-directed polymerase chain reactions (PCRs): cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV), and Toxoplasma gondii. More than 50% of all presumed intraocular infections fail to have a pathogen identified. 1 Metagenomic deep sequencing has the potential to improve diagnostic yield as it is inherently unbiased and hypothesis-free -it can theoretically detect all pathogens in a clinical sample and simultaneously provide genetic information that may be used for epidemiological investigations and antimicrobial susceptibility. 2, 3 Further, technical advances in metagenomic deep sequencing and bioinformatics have made it increasingly feasible for the translational application of this technology to the clinical setting (http://www.ciapm.org). Previously, we have demonstrated that unbiased RNA sequencing (RNA-seq) of intraocular fluid can detect fungi, parasites, DNA and Library Preparation and Sequencing. DNA was isolated from 50 μL of each vitreous sample using the DNeasy Blood & Tissue Kit (QIAGEN, Germantown, MD) per the manufacturer's recommendations. The DNA was eluted in 9 μL of the kit elution buffer and stored at -20°C.
DNA was quantified using the Qubit® dsDNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA). 5 μL of the extracted DNA were used to prepare DNA-seq libraries using the Nextera XT DNA Library Preparation Kit (Illumina, San Diego, CA) according to the manufacturer's recommendations and amplified with 12 PCR cycles. Library size and concentration were determined using the Blue Pippin (Sage Science, Beverly, MA) and Kapa Universal quantitative PCR kit (Kapa Biosystems, Woburn, MA), respectively. Samples were sequenced to an average depth of ~15 X 10 6 reads/sample on an Illumina HiSeq 4000 instrument using 125 nucleotide (nt) paired-end sequencing. 8, 9 A water ("no-template") control was included in each library preparation.
Bioinformatics. Sequencing data were analyzed using a rapid computational pipeline developed by the DeRisi Laboratory to classify MDS reads and identify potential pathogens by comparison to the entire NCBI nucleotide (nt) reference database. 2, 8 Briefly, the pipeline consists of the following steps. First, an initial human-sequence removal step is accomplished by alignment of all paired-end reads to the human reference genome 38 (hg38) and the Pan troglodytes genome (panTro4, 2011, UCSC), using the Spliced Transcripts Alignment to a Reference (STAR) aligner (v2.5.1b). 10 Unaligned reads were quality filtered using PriceSeqFilter 11 with the "-rnf 90" and "rqf 85 0.98" settings. Reads passing QC were then subjected to duplicate removal. The remaining reads that were at least 95% identical were compressed by cd-hit-dup (v4.6.1). 12 Paired reads were then assessed for complexity by compression with the LZW algorithm. 13 Read-pairs with a compression score less than 0.45 were subsequently removed. Next, a second phase of human removal was conducted using the very-sensitive-local mode of Bowtie2 (v2. 2.4) with the same hg38 and PanTro4 reference as described above. 14 Read pairs, in which both members remained unmapped, were then passed on to GSNAPL (v2015-12-31). 15 At this step, read-pairs were aligned to the NCBI nt database (downloaded July 2015, indexed with k=16mers), and preprocessed to remove known repetitive sequence with RepeatMasker (vOpen-4.0) (www.repeatmasker.org). Finally, reads were aligned to the NCBI non-redundant nucleotide (nr) database (July 2015) using the Rapsearch2 algorithm. 16 For the purpose of this study, human infectious agents detected by our pipeline were manually inspected using Bowtie2 to align against full-length reference genomes. Geneious (Biomatters, Ltd., Auckland, New Zealand) was used for visualization. No absolute or relative read counts were used to determine a call.
Specifically, any infectious agent that had ≥ 2 non-overlapping reads to the reference pathogen genome was considered positive if it met both of the following criteria: (1) It is a pathogen known to be a cause of infectious uveitis and (2) reads from this pathogen were not present in the no-template ("water only") control on the same run and library preparation. Characteristics of metagenomic DNA sequencing. Non-host sequences represented a small fraction (0.7% ± 2.5%, mean ± SD) of the total number of reads consistent with prior metagenomic deep sequencing of clinical samples. 2, 3 The number of reads for the pathogen identified ranged from 2 to 166,691 reads or 0.045 to 9446 matched read pairs per million read pairs (rM) at the species level based on nucleotide alignment (Figure 2A ). Of the samples considered pathogen positive by DNA-seq, the starting DNA concentration was significantly higher than samples that were considered pathogen negative (0.63 ± 1.05 vs 0.28 ± 0.95 ng/μL, mean ± SD, p = 0.01, Figure 2B ), although a low DNA concentration did not exclude the identification of a pathogen or vice versa. In this study, the vitreous sample with the highest DNA concentration, 5.06 ng/μL, was not positive for a pathogen, suggesting that inflammatory cell infiltration may be robust even in the absence of infection.
Antiviral drug mutation analysis with metagenomic DNA sequencing. An advantage of metagenomic deep sequencing is the ability to apply sequence information to infer the phenotypic behavior of the identified pathogen. As a proof-of-concept, we compared samples in which CMV sequences were adequately recovered for the UL54 and UL97 genes, coding for the DNA polymerase and phosphotransferase respectively, and compared to a CMV antiviral drug resistance database developed at Stanford University 18, 19 . Of the 7 samples analyzed, 3 had mutations in UL97 that confer ganciclovir and valganciclovir resistance. Two samples were found to have C592G mutations, and 1 sample had both C592G and L595S mutations ( Table 3) .
No drug resistance mutations were identified in UL54.
DISCUSSION
In this study, we showed that metagenomic DNA sequencing can detect most infections found by pathogen-directed PCR, with a positive agreement rate of 87% in intraocular fluid clinical samples. Further, DNA-seq detected a pathogen in an additional 22% of the samples that were either missed or cannot be detected with the available pathogen-directed PCR panel validated for ocular samples. These results highlight the robustness of DNA-seq given that different DNA extraction protocols were used and the samples that underwent DNA-seq were subjected to multiple additional freeze-thaw cycles compared to the original PCR testing.
DNA-seq correctly identified all HSV and CMV positive reference clinical samples. For the 4
pathogen-directed PCRs, DNA-seq was more sensitive than CMV-directed PCR as it identified an additional 2 samples with CMV DNA, but was less sensitive than T. gondii-directed PCR (62.5%, 5 out 8 samples). T. gondii is a widespread protozoan parasite with a 63 megabase-pair (Mbp) genome that includes 35 B1 gene repeats. 20 The Proctor assay is a nested-PCR targeting the B1 gene with a limit of detection of ~5 T. gondii genomes/µL or 20 genomes/reaction. The lower sensitivity of DNA-seq for T. gondii compared to the Proctor assay is surprising given that this shotgun approach can theoretically detect the entire 63 Mbp genome of T. gondii. However, the pre-analytical techniques employed in this study may not be optimized for the detection of T.
gondii. Future experiments comparing different intraocular specimen types, including fresh and frozen samples, as well as evaluation of extraction methods and library preparation protocols, may be necessary to improve T. gondii detection without compromising the sensitivity of other pathogens. Furthermore, it is possible that RNA-seq may provide better T. gondii sensitivity in intraocular fluid samples as prior work showed that this method can detect RNA from this organism with high genome coverage. 2 While RNA was not available for evaluation from the samples used in this study these data suggest that a combined approach should be assessed, whereby both the RNA and DNA fractions are independently examined by metagenomic sequencing.
The benefit of target agnostic nature metagenomic sequencing is apparent here when applied to clinical samples that have tested negative with available pathogen-directed PCR assays. Of the 36 samples that tested negative at Proctor, 8 samples were positive for an intraocular pathogen with DNA-seq. Therefore, one in five patients with negative conventional testing had an intraocular infection that could have been more effectively treated. The number of missed pathogens is likely an underestimation, as DNA-seq cannot detect RNA viruses, such as rubella.
These data suggests a practical diagnostic decision tree whereby samples negative by routine PCR are then advanced to metagenomic DNA and RNA sequencing.
An advantage of metagenomic sequencing is the ability to capture a large percentage of the organism's genome, if not its entirety. Sequencing data can provide useful clinical information such as drug resistance. For 70% of the samples that were CMV positive by DNA-seq, coverage in the UL54 and UL97 genes allowed assessment for antiviral drug resistance mutations. We found that 43% of the samples (3 out of 7) analyzed had ganciclovir resistance mutations in the phosphotransferase gene (UL97). The two mutations identified were two of the most common CMV drug resistance mutations, 21 indicating that these mutations were unlikely to represent sequencing errors. A caveat in interpreting these results is that the authors do not have information on the medication history of the patients identified to have ganciclovir resistant CMV infections.
In summary, we have shown that metagenomic DNA sequencing can detect a wide range of pathogens including bacteria, fungi, parasites, and DNA viruses in intraocular samples, concurrently provide drug resistance information, and improve diagnostic yield for samples that have failed conventional diagnostics. This approach will not only complement the current diagnostic paradigm in ophthalmology but also allow for a more comprehensive characterization of the etiology of infectious uveitis. 
